Hagen Gerecke

Title: Hagen Gerecke: Innovator in Pharmaceutical Chemistry

Introduction

Hagen Gerecke is a notable inventor based in Jena, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 6 patents. His work primarily focuses on methods for synthesizing complex chemical compounds that have important applications in medicine.

Latest Patents

One of his latest patents is titled "Method for preparing 4-[17β-methoxy-17α-methoxymethyl-3-oxoestra-4,9-dien-11β-yl]benzaldehyde (E)-oxime (asoprisnil)." This invention describes a reliable and reproducible method for preparing asoprisnil, which is characterized by excellent physical stability, making it particularly suitable for the manufacture of solid pharmaceutical forms such as tablets and coated tablets. Another significant patent is the "Process for production of crystals of 11β-benzaldoxim-estra-4,9-diene derivatives." This process involves creating crystals with specific particle sizes through a wet milling technique, which is crucial for developing pharmaceutical preparations.

Career Highlights

Throughout his career, Hagen Gerecke has worked with prominent companies in the pharmaceutical industry, including Jenapharm GmbH & Co. KG and Schering Aktiengesellschaft. His experience in these organizations has allowed him to refine his expertise in chemical synthesis and pharmaceutical development.

Collaborations

Hagen has collaborated with several professionals in his field, including Michael Dittgen and Sabine Fricke. These collaborations have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Hagen Gerecke's innovative work in pharmaceutical chemistry has led to the development of important methods and compounds that enhance the effectiveness of medical treatments. His contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.